JustChartThings

Biotech Season Off to a Good Start

Long
NASDAQ:PIRS   Pieris Pharmaceuticals, Inc.

PIRS catching some short covering perhaps near end of the day, sending it up near the critical 5 area. Low 4s held very well after a month long run and consolidation. Expecting this to breakout over 5 barring any extraordinary news; not following company details but certainly ripe for a catalyst. Wouldn't be surprised with upgrade ratings or purchase disclosures in the coming weeks that may drive it further in the near-term.

Biotech seasonality is upon us, further adding to my long bias here.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.